13 November 2018 - - US-based biopharmaceutical company Gilead Sciences, Inc. (NASDAQ: GILD) has presented new data from the company's clinical development programme for advanced fibrosis due to nonalcoholic steatohepatitis, the company said.
13 November 2018 - - US-based biopharmaceutical company Gilead Sciences, Inc. (NASDAQ: GILD) has presented results from studies investigating Epclusa (sofosbuvir 400mg/velpatasvir 100mg) in chronic hepatitis C virus infected patients with severe...
13 November 2018 - - US-based RNAi therapeutics company Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), the leading, announced TODAY that the company presented updated results from the ongoing Phase 1/2 open-label extension study of givosiran, an ...
13 November 2018 - - US-based immunotherapy company Alpine Immune Sciences, Inc. (NASDAQ: ALPN) has advanced its oncology programme, the company said.

Following promising preclinical data presented TODAY at the Society for Immunotherapy ...
13 November 2018 - - US-based biotechnology company Obsidian Therapeutics, Inc has presented preclinical data demonstrating fine-tuned regulation of cytokine production and CAR-T function using Destabilizing Domains paired with FDA-approved small mol...